Flumetasone
Clinical data | |
---|---|
Other names | Flumethasone (USAN) |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | Topical |
ATC code | |
Pharmacokinetic data | |
Metabolism | Hepatic, CYP3A4-mediated |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.016.701 |
Chemical and physical data | |
Formula | C22H28F2O5 |
Molar mass | 410.458 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Flumetasone, also known as flumethasone,[1] is a corticosteroid for topical use.
It was patented in 1951 and approved for medical use in 1964.[2]
Chemistry
Flumethasone is 420 times as potent as cortisone in an animal model for anti-inflammatory activity.
Names
Trade names include Locacorten, Locorten, and Orsalin. It is available in combination with clioquinol, under the trade name Locacorten-Vioform (in some countries Locorten-Vioform), for the treatment of otitis externa and otomycosis. It is usually formulated as the pivalic acid ester prodrug called flumetasone pivalate.
See also
References
- ↑ Morton IK, Hall JM (1999). Concise Dictionary of Pharmacological Agents Properties and Synonyms. Dordrecht: Springer Netherlands. p. 122. ISBN 9789401144391.
- ↑ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 484. ISBN 9783527607495.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.